{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:18:37Z","timestamp":1783167517474,"version":"3.54.6"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["AHA-09CRP2251004"],"award-info":[{"award-number":["AHA-09CRP2251004"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["68633259"],"award-info":[{"award-number":["68633259"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Excessive cholesterol accumulation in macrophages is the pivotal step underlying atherosclerotic plaque formation. We here explore factors in the serum of patients with RA, and mechanisms through which they interact with and influence cholesterol loading capacity (CLC) of macrophages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a cross-sectional observational cohort of 104 patients with RA, CLC was measured as intracellular cholesterol content in human THP-1\u2013derived macrophages after incubation with patient serum. Low-density lipoprotein (LDL) oxidation was measured in terms of oxidized phospholipids on apoB100-containing particles (oxPL-apoB100). Antibodies against oxidized LDL (anti-oxLDL), proprotein convertase subtilisin\/Kexin type-9 (PCSK9) and high-sensitivity CRP were also quantified. All analyses adjusted for atherosclerotic cardiovascular disease (ASCVD) risk score, obesity, total LDL, statin use, age at diagnosis, and anti-oxLDL IgM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>OxPL-apoB100, anti-oxLDL IgG and PCSK9 were positively associated with CLC (all P\u2009&amp;lt;\u20090.020). OxPL-apoB100 directly influenced CLC only in dual RF- and ACPA-positive patients [unstandardized b (95% bootstrap CI)=2.08 (0.38, 3.79)]. An indirect effect of oxPL-apoB100 on CLC through anti-oxLDL IgG increased, along with level of CRP [index of moderated mediation\u2009=\u20090.55 (0.05\u20131.17)]. CRP also moderated yet another indirect effect of oxPL-apoB100 on CLC through upregulation of PCSK9, but only among dual-seropositive patients [conditional indirect effect\u2009=\u20090.64 (0.13\u20131.30)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Oxidized LDL can directly influence CLC in dual-seropositive RA patients. Two additional and independent pathways\u2014via anti-oxLDL IgG and PCSK9\u2014may mediate the effects of oxPL-apoB100 on CLC, depending on CRP and seropositivity status. If externally validated, these findings may have clinical implications for cardiovascular risk prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac394","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T09:48:46Z","timestamp":1657360126000},"page":"1254-1263","source":"Crossref","is-referenced-by-count":7,"title":["Serum cholesterol loading capacity of macrophages is regulated by seropositivity and C-reactive protein in rheumatoid arthritis patients"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-1563","authenticated-orcid":false,"given":"George A","family":"Karpouzas","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Harbor-UCLA Medical Center, The Lundquist Institute , Torrance, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Papotti","sequence":"additional","affiliation":[{"name":"Department of Food and Drug, University of Parma , Parma,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R","family":"Ormseth","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Harbor-UCLA Medical Center, The Lundquist Institute , Torrance, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Department of Food and Drug, University of Parma , Parma,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth\u00a0","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Harbor-UCLA Medical Center, The Lundquist Institute , Torrance, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Marchi","sequence":"additional","affiliation":[{"name":"Department of Food and Drug, University of Parma , Parma,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Zimetti","sequence":"additional","affiliation":[{"name":"Department of Food and Drug, University of Parma , Parma,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9616-1946","authenticated-orcid":false,"given":"Matthew J","family":"Budoff","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Harbor-UCLA Medical Center and The Lundquist Institute , Torrance, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Ronda","sequence":"additional","affiliation":[{"name":"Department of Food and Drug, University of Parma , Parma,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,9]]},"reference":[{"key":"2026041420125682800_keac394-B1","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avi\u00f1a-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2026041420125682800_keac394-B2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2017-211735","article-title":"Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis","volume":"77","author":"Crowson","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026041420125682800_keac394-B3","doi-asserted-by":"crossref","first-page":"20963","DOI":"10.1074\/jbc.272.34.20963","article-title":"Low density lipoprotein oxidation and its pathobiological significance","volume":"272","author":"Steinberg","year":"1997","journal-title":"J Biol Chem"},{"key":"2026041420125682800_keac394-B4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.39039","article-title":"Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism","volume":"67","author":"Ronda","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026041420125682800_keac394-B5","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/1535370213503262","article-title":"Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages","volume":"238","author":"Voloshyna","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"key":"2026041420125682800_keac394-B6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"2026041420125682800_keac394-B7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-90-481-8622-8_8","article-title":"Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis","volume":"51","author":"Miller","year":"2010","journal-title":"Subcell Biochem"},{"key":"2026041420125682800_keac394-B8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jcmm.12689","article-title":"Macrophage-mediated cholesterol handling in atherosclerosis","volume":"20","author":"Chistiakov","year":"2016","journal-title":"J Cell Mol Med"},{"key":"2026041420125682800_keac394-B9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MOL.0b013e328308b622","article-title":"The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity","volume":"19","author":"Tsimikas","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"2026041420125682800_keac394-B10","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma","volume":"49","author":"Bergmark","year":"2008","journal-title":"J Lipid Res"},{"key":"2026041420125682800_keac394-B11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacc.2016.10.057","article-title":"Oxidized phospholipids on apolipoprotein B-100 and recurrent ischemic events following stroke or transient ischemic attack","volume":"69","author":"Byun","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026041420125682800_keac394-B12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.ATV.14.1.32","article-title":"Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL","volume":"14","author":"Yl\u00e4-Herttuala","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"2026041420125682800_keac394-B13","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1194\/jlr.M600064-JLR200","article-title":"OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages","volume":"47","author":"Saad","year":"2006","journal-title":"J Lipid Res"},{"key":"2026041420125682800_keac394-B14","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00018-013-1289-1","article-title":"Inflammation and immune system interactions in atherosclerosis","volume":"70","author":"Legein","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"2026041420125682800_keac394-B15","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/01.ATV.19.7.1600","article-title":"Oxidized LDL\u2013containing immune complexes induce Fc gamma receptor I\u2013mediated mitogen-activated protein kinase activation in THP-1 macrophages","volume":"19","author":"Huang","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026041420125682800_keac394-B16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","article-title":"Autoantibody against oxidised LDL and progression of carotid atherosclerosis","volume":"339","author":"Salonen","year":"1992","journal-title":"Lancet"},{"key":"2026041420125682800_keac394-B17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.ATV.21.1.95","article-title":"Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor\u2013deficient mice","volume":"21","author":"Tsimikas","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026041420125682800_keac394-B18","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/cvr\/cvy079","article-title":"PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages","volume":"114","author":"Ding","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2026041420125682800_keac394-B19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/joim.12758","article-title":"PCSK9 plays a novel immunological role in oxidized LDL\u2013induced dendritic cell maturation and activation of T cells from human blood and atherosclerotic plaque","volume":"284","author":"Liu","year":"2018","journal-title":"J\u00a0Intern Med"},{"key":"2026041420125682800_keac394-B20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.5551\/jat.RV17003","article-title":"PCSK9 and atherosclerosis \u2013 lipids and beyond","volume":"24","author":"Shapiro","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"2026041420125682800_keac394-B21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/ehjcvp\/pvz022","article-title":"PCSK9 and inflammation: a review of experimental and clinical evidence","volume":"5","author":"Momtazi-Borojeni","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026041420125682800_keac394-B22","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/ar2129","article-title":"Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2","volume":"9","author":"Lourida","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"2026041420125682800_keac394-B23","doi-asserted-by":"crossref","first-page":"58.1","DOI":"10.1136\/annrheumdis-2021-eular.3397","article-title":"OP0104 Differences in low-density lipoprotein (LDL) particle composition and oxidation may underlie the paradoxical association of low LDL with higher coronary atherosclerosis burden in rheumatoid arthritis [abstract]","volume":"80","author":"Karpouzas","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2026041420125682800_keac394-B24","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s10067-010-1436-0","article-title":"Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis","volume":"29","author":"Ahmed","year":"2010","journal-title":"Clin Rheumatol"},{"key":"2026041420125682800_keac394-B25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.plipres.2006.05.001","article-title":"Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis","volume":"45","author":"Matsuura","year":"2006","journal-title":"Prog Lipid Res"},{"key":"2026041420125682800_keac394-B26","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072157","article-title":"Anti-atherogenic modification of serum lipoprotein function in patients with rheumatoid arthritis after tocilizumab treatment, a pilot study","volume":"9","author":"Greco","year":"2020","journal-title":"J Clin Med"},{"key":"2026041420125682800_keac394-B27","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am J Med"},{"key":"2026041420125682800_keac394-B28","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1136\/annrheumdis-2013-203617","article-title":"Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease","volume":"73","author":"Karpouzas","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026041420125682800_keac394-B29","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0735-1097(00)01180-3","article-title":"Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein","volume":"37","author":"Penny","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026041420125682800_keac394-B30","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/ard.2010.142737","article-title":"High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids","volume":"70","author":"McMahon","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2026041420125682800_keac394-B31","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.ATV.20.3.689","article-title":"In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression","volume":"20","author":"Tsimikas","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026041420125682800_keac394-B32","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.0000028465.52694.9B","article-title":"Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma","volume":"106","author":"Aikawa","year":"2002","journal-title":"Circulation"},{"key":"2026041420125682800_keac394-B33","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/01.CIR.0000141728.23033.B5","article-title":"High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial","volume":"110","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"2026041420125682800_keac394-B34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.ATV.0000251501.86410.03","article-title":"Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression","volume":"27","author":"Tsimikas","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026041420125682800_keac394-B35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/bmm.11.60","article-title":"Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events","volume":"5","author":"Taleb","year":"2011","journal-title":"Biomark Med"},{"key":"2026041420125682800_keac394-B36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.ATV.0000157979.51673.2c","article-title":"C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein","volume":"25","author":"van Tits","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026041420125682800_keac394-B37","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3892\/ijmm.2012.1072","article-title":"PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-\u03baB activation in THP-1-derived macrophages","volume":"30","author":"Tang","year":"2012","journal-title":"Int J Mol Med"},{"key":"2026041420125682800_keac394-B38","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3109\/14397595.2015.1128871","article-title":"Plasma sLOX-1 is a potent biomarker of clinical remission and disease activity in patients with seropositive RA","volume":"26","author":"Ishikawa","year":"2016","journal-title":"Mod Rheumatol"},{"key":"2026041420125682800_keac394-B39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/cvr\/cvw053","article-title":"Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms","volume":"110","author":"Tavori","year":"2016","journal-title":"Cardiovasc Res"},{"key":"2026041420125682800_keac394-B40","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.39098","article-title":"Disease activity in rheumatoid arthritis and the risk of cardiovascular events","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026041420125682800_keac394-B41","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/annrheumdis-2016-211066","article-title":"Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks","volume":"76","author":"Holmqvist","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026041420125682800_keac394-B42","year":"2021"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac394\/45194356\/keac394.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/3\/1254\/49355866\/keac394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/3\/1254\/49355866\/keac394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:22:03Z","timestamp":1776212523000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/3\/1254\/6637528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac394","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2022,7,9]]}}}